This antibody recognizes an extracellular epitope of CD267, a 32 kDa type III transmembrane protein expressed by B cells and possibly by some activated T cells.
Applications
Flow Cytometry
Dilutions
Flow Cytometry: The reagent is designed for analysis of human blood cells using 10 µl reagent / 100 µl of whole blood or 106 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
Reactivity
Human
Immunogen
CD267 transfected RBL cells.
Host
Rat
Clonality
Monoclonal
Clone ID
1A1
Isotype
IgG2a
Light Chains
kappa
Conjugate
APC
Excitation: 645nm, Emission: 660nm
Purification
This antibody is conjugated with Allophycocyanin (APC) under optimum conditions. The conjugate is purified by size-exclusion chromatography; removing unconjugated antibody and free fluorochrome.
Predicted MW
32 kDa
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline, pH 7.4, with 15 mM Sodium Azide.
Storage
Shipped at 4°C. Store in the dark at 2-8°C. Do not freeze!
Synonyms
CD267, TNFRSF13B, Transmembrane activator and CAML interactor, Tumor necrosis factor receptor superfamily member 13B
Flow cytometric analysis of human peripheral whole blood stained using Anti-CD267 Antibody [1A1] (APC) (10µl reagent per 100µl of peripheral whole blood).
Flow cytometric analysis of human lymphocytes using Anti-CD267 Antibody [1A1] (APC) (10µl reagent per 100µl of peripheral whole blood) and Anti-CD19 Antibody [LT19] (PE) (20µl reagent per 100µl of peripheral whole blood).
Separation of human CD267 positive CD19 positive lymphocytes (red-filled) from human CD267 negative CD19 negative lymphocytes (black-dashed) in flow cytometry analysis of human peripheral whole blood using Anti-CD267 Antibody [1A1] (APC) (10µl reagent per 100µl of peripheral whole blood).
Publishing research using Anti-TACI Antibody [1A1] (APC) (A121897)? Please let us know so that we can list the citation on this page.